[Centrosome isolation from cultured bladder cancer cells--p53 mutation and centrosome hyperamplification].
Centrosome hyperamplification occurs frequently in human cancers, and is the major contributing factor for chromosomal instability and aneuploidy. We examined centrosome hyperamplification in bladder cancer cell lines. Samples were incubated with antibodies to the centrosome protein gamma-tubulin. The cell line (RT-4), which has a wild-type p53 status, showed a well-regulated centrosome replication cycle. On the other hand, centrosome hyperamplification was observed in HT-1197 and HT-13r cancer cells by discontinuous sucrose gradient fractionation. We used sucrose gradient fractions enriched for centrosomes by the immunoblot analysis for the presence of gamma-tubulin, a major component of centrosomes. The fractions were then immunoblotted with anti-nucleophosmin/B23 (NPM) antibody. NPM is a primary target of CDK2-cyclin E in the initiation of centrosome duplication. The profile of NPM closely paralleled that of gamma-tubulin, suggesting the association of NPM with the centrosome. Identification of the mechanism underlying the replication of the centrosome should lead to the understanding of the mechanism of chromosomal instability in bladder cancer, and enable us to develop cancer therapeutics targeted to centrosome replication.
Kawamura
Kenji
K
Department of Urology, Kanazawa Medical University.
Moriyama
Manabu
M
Suga
Koudai
K
Shiba
Nobuyuki
N
Tanaka
Tatsuro
T
Ikeda
Ryosuke
R
Suzuki
Koji
K
D018385:Centrosome / Q000473:pathology*; D019927:Cyclin E / Q000235:genetics; D005784:Gene Amplification; D006801:Humans; D009154:Mutation; D014407:Tumor Cells, Cultured; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*; D014461:Ultracentrifugation; D001749:Urinary Bladder Neoplasms / Q000235:genetics / Q000473:pathology*
D019927:Cyclin E; D016159:Tumor Suppressor Protein p53